All
September Childhood Cancer Awareness Month: Lace Up for Kids 2022
Each year, more than 400,000 children around the world are diagnosed with cancer; however, advancements in care and treatment have, in many cases, not changed in decades. That’s why we’re determined to change the future for kids with cancer and their families. Join us this September Childhood Cancer Awareness Month, as we all shine a…
ETMR Brain Cancer: Advancing Treatment Protocol
Embryonal tumor with multilayered rosettes (ETMR) attacks the youngest, most vulnerable patients — infants. In fact, 92% of patients affected by ETMR brain cancer are under the age of three at diagnosis. For the first time, experts are addressing the challenges of ETMR and developing the first treatment protocol with international collaboration. This article covers…
Medulloblastoma in Children
What is Medulloblastoma? Medulloblastoma is an aggressive brain tumor that originates in the brain’s cerebellum — an area that regulates a person’s balance and sense of equilibrium. According to the National Library of Medicine, “Medulloblastoma is the most common malignant brain tumor in children, constituting nearly 20% of all pediatric brain tumors.” While this type…
A Neuroblastoma Journey: From Diagnosis to MiNivAn Trial
Poppy was just shy of her fifth birthday when she started experiencing pain in her legs, increasing lethargy and a diminished appetite. As her leg pain worsened, her mother called Poppy’s primary care provider to request an appointment. The doctor ran blood tests and sent the family home. Days later, Poppy’s mom, Claire, received a…
Advancing DIPG Cancer Research & What It Means for Patients
Diffuse intrinsic pontine glioma (DIPG) tumors are extremely difficult to treat due to their anatomical location. But advancements in research and greater DIPG awareness are leading to more hope for patients with this type of rare pediatric brain tumor. This article covers the basics of DIPG cancer, what advancements in research mean for patients, and…
Fertility Issues for Childhood Cancer Survivors
When pediatric cancer patients are fighting for their lives, parents have to stay laser-focused on the here and now. As a result, there is often little room for thoughts about the late effects of cancer treatment on children— including fertility preservation for cancer patients. But according to Dr. Sogol Mostoufi-Moab, MD, MSCE, a dual-certified pediatric…
CME Sessions Can Also Benefit Parents
CME (Continuing Medical Education) sessions or activities serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. SKC occasionally participates in sponsored CME sessions for researchers and healthcare professionals. The following sessions may be of interest to parents.…
Orphan Drugs & Their Impact on Rare Childhood Cancers
Having a child with rare cancer that has no established treatment protocol can leave you feeling like you have nowhere to turn. But as science continues to progress, new and innovative cancer treatments are becoming more available. These treatments are called orphan drugs, and in this article, we explain what they are, how the US…
Clinical Trials: What to Expect and How to Advocate for Your Child
Clinical trials are a vital part of scientific research. When a researcher is developing a new therapy or treatment, clinical trials are how they make sure it’s safe and effective before it can become widely available. Oftentimes, a clinical trial is used to learn if a new treatment has less harmful side effects than the…
Podcast & Webinars
Check Out This Week in Pediatric Oncology (TWIPO): A Podcast Dedicated to Sharing Ideas & Working Together for Cures
Childhood cancer is a complicated disease. Whether you’re a clinician, researcher yourself or caring for a child with cancer, we want to give you the tools to deepen your understanding. For more than a decade, Solving Kids’ Cancer has earned a seat at the table among some of the most inspiring researchers and like-minded organizations…
Press Release
Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma
Solving Kids’ Cancer, The Catherine Elizabeth Blair Memorial Foundation, and Wade’s Army awarded a $136,000 grant to support the novel immunotherapy clinical trial for childhood cancer. Researchers will use a humanized monoclonal antibody linked to IL2, known as hu14.18-IL2, which specifically targets neuroblastoma tumor cells and binds to them, while the IL2 activates NK cells…
Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany
Solving Kids’ Cancer has partnered with Band of Parents, Joining Against Cancer in Kids (J-A-C-K), and Solving Kids’ Cancer Europe, to advance new treatment options for children with neuroblastoma with the launch of a transatlantic Phase I clinical trial that is open for enrollment in the U.K. and will open soon in the US and Germany…
The Childhood Cancer STAR Act has been Signed!
The childhood cancer community and Solving Kids’ Cancer are grateful to our many champions in Congress, who successfully shepherded this bipartisan bill through both chambers. As a member of the Coalition Against Childhood Cancer (CAC2), we were proud to play a role in advancing and advocating for this legislation alongside CAC2’s advocacy partner coalition, the Alliance for Childhood Cancer, and the entire childhood cancer community.
Solving Kids’ Cancer 2018 Spring Celebration
On Wednesday, May 16th, Solving Kids’ Cancer (SKC), an NYC based nonprofit, held its annual Spring Celebration benefit gala at the Mandarin Oriental New York. Mikhail “Doctor Mike” Varshavski served as the Master of Ceremonies of the event, which was hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young and raised over $575,000 for pediatric cancer research.
Solving Kids’ Cancer to honor two industry leaders at 2018 Annual Spring Celebration Gala
On Wednesday, May 16th, Solving Kids’ Cancer (SKC) will hold its annual Spring Celebration Benefit Gala. This event, SKC’s signature research fundraiser, draws industry leaders from across the nation to celebrate distinguished individuals who have contributed to the advancement of pediatric cancer therapies. The 2018 honorees are Usman “Oz” Azam, MD, President and CEO of Tmunity Therapeutics and Thomas Gad, Founder and President of Y-mAbs Therapeutics.
Brain Tumor Clinical Trial Now Enrolling Children
A Phase 1 clinical trial leveraging the re-engineered poliovirus is now open for enrollment to children 12 years and older at the Preston Robert Tisch Brain Tumor Center, Duke University Medical Center. After years of following the progress of this promising therapy against adult glioblastoma and working with the research team on behalf of children, Solving Kids’ Cancer teamed up with The Andrew McDonough B+ Foundation to help move this forward in a trial for pediatric brain tumor patients.
Targeted Therapy for Children with ALK-Driven Neuroblastoma
Lorlatinib, an investigational drug candidate currently in late-stage clinical development for the treatment of lung cancer may also prove effective for the treatment of the pediatric cancer neuroblastoma. Solving Kids’ Cancer is leading an international effort of like-minded nonprofits to provide nearly $400,000 of collaborative funding for an innovative clinical trial to bring a potentially life-saving therapy to kids.
Advocacy in Action
Solving Kids’ Cancer was the first charity to ever go against the UK healthcare system without a pharmaceutical company involved. As a result, the National Institute for Health and Care Excellence (NICE) recently announced that it has upheld SKC’s appeal against the Institute’s decision not to recommend dinutuximab for treating high-risk neuroblastoma.
Precision Medicine Advances for Children With Neuroblastoma
Solving Kids’ Cancer (SKC) together with Wade’s Army announce their joint financial support of this Phase 1 clinical trial to test the safety and efficacy of various investigational drugs that will leverage precision medicine for children with neuroblastoma. This Next Generation Personalized Neuroblastoma Therapy – also known as NEPENTHE (Greek for “medicine for sorrow”) – is the first precision medicine trial for children that will robustly analyze the genomics of their cancer and use combinations of investigational drugs to target specific mutations in their tumors.
News & Views
September Childhood Cancer Awareness Month: Lace Up for Kids 2022
Each year, more than 400,000 children around the world are diagnosed with cancer; however, advancements in care and treatment have, in many cases, not changed in decades. That’s why we’re determined to change the future for kids with cancer and their families. Join us this September Childhood Cancer Awareness Month, as we all shine a…
ETMR Brain Cancer: Advancing Treatment Protocol
Embryonal tumor with multilayered rosettes (ETMR) attacks the youngest, most vulnerable patients — infants. In fact, 92% of patients affected by ETMR brain cancer are under the age of three at diagnosis. For the first time, experts are addressing the challenges of ETMR and developing the first treatment protocol with international collaboration. This article covers…
Medulloblastoma in Children
What is Medulloblastoma? Medulloblastoma is an aggressive brain tumor that originates in the brain’s cerebellum — an area that regulates a person’s balance and sense of equilibrium. According to the National Library of Medicine, “Medulloblastoma is the most common malignant brain tumor in children, constituting nearly 20% of all pediatric brain tumors.” While this type…
A Neuroblastoma Journey: From Diagnosis to MiNivAn Trial
Poppy was just shy of her fifth birthday when she started experiencing pain in her legs, increasing lethargy and a diminished appetite. As her leg pain worsened, her mother called Poppy’s primary care provider to request an appointment. The doctor ran blood tests and sent the family home. Days later, Poppy’s mom, Claire, received a…
Advancing DIPG Cancer Research & What It Means for Patients
Diffuse intrinsic pontine glioma (DIPG) tumors are extremely difficult to treat due to their anatomical location. But advancements in research and greater DIPG awareness are leading to more hope for patients with this type of rare pediatric brain tumor. This article covers the basics of DIPG cancer, what advancements in research mean for patients, and…
Fertility Issues for Childhood Cancer Survivors
When pediatric cancer patients are fighting for their lives, parents have to stay laser-focused on the here and now. As a result, there is often little room for thoughts about the late effects of cancer treatment on children— including fertility preservation for cancer patients. But according to Dr. Sogol Mostoufi-Moab, MD, MSCE, a dual-certified pediatric…
CME Sessions Can Also Benefit Parents
CME (Continuing Medical Education) sessions or activities serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. SKC occasionally participates in sponsored CME sessions for researchers and healthcare professionals. The following sessions may be of interest to parents.…
Orphan Drugs & Their Impact on Rare Childhood Cancers
Having a child with rare cancer that has no established treatment protocol can leave you feeling like you have nowhere to turn. But as science continues to progress, new and innovative cancer treatments are becoming more available. These treatments are called orphan drugs, and in this article, we explain what they are, how the US…
Clinical Trials: What to Expect and How to Advocate for Your Child
Clinical trials are a vital part of scientific research. When a researcher is developing a new therapy or treatment, clinical trials are how they make sure it’s safe and effective before it can become widely available. Oftentimes, a clinical trial is used to learn if a new treatment has less harmful side effects than the…
Videos
Give Hope & Love
When the world entered the COVID-19 pandemic, all we needed was a little Hope & Love. We asked all of our young ambassadors to share their messages of hope to the world. A big thank you to all of the frontline workers who risked their lives during the world pandemic. From all of us at Solving Kids’ Cancer
Lace Up For Kids 2019: Childhood Cancer Awareness Month
The “Lace Up For Kids” campaign connected childhood cancer supporters and advocates both nationally and internationally. For the month of September, thousands of gold shoelaces were shipped and worn to help raise awareness for Childhood Cancer Awareness Month. Take a look at some of the people who participated – you may even recognize some influencers and celebrities!
2018 Spring Celebration
On Wednesday, May 16th, Solving Kids’ Cancer (SKC), an NYC based nonprofit, held its annual Spring Celebration benefit gala at the Mandarin Oriental New York. Mikhail “Doctor Mike” Varshavski served as the Master of Ceremonies of the event, which was hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young and raised over $575,000 for pediatric cancer research.
2016: A Year at a Glance for SKC
Join us and watch as we recap all of the milestones & events Solving Kids’ Cancer experienced during 2016. From our 6th Annual Spring Celebration to SKC appealing NICE’s decision in the UK – none of these accomplishments could have been possible without the help of our supporters. Thank you & Happy New Year!
Meet the Inspiring Kids of Runway Heroes 2016
Runway Heroes is a fun-filled fashion show featuring childhood cancer fighters and survivors ranging in age from 3 to 13 years of age. The runway is presented by Bloomingdale’s at its flagship Manhattan store, and benefits Solving Kids’ Cancer and the Ronan Thompson Foundation, two like-minded nonprofits that collaborate on funding innovative childhood cancer research. In high fashion and chic style, these runway stars shine with a sense of pride and accomplishment as they strut their stuff in trend-setting outfits donated by Bloomingdale’s.
Highlights from the 2016 Spring Celebration Gala
On Monday, May 16th, Solving Kids Cancer held its 7th Annual Spring Celebration honoring Gary Armen, Ph.D., Chairman and CEO of Agenus, who received the Wings of Hope Award. Good Morning America News Anchor, Amy Robach, served as the Mistress of Ceremonies. The event, which raised over $750,000, was hosted by Donna Karan, Gabby Karan De Felice, Bonnie Young, Jan Planit, and Latham Thomas. The 2016 benefit celebrated the renewal of spring and children everywhere. The evening included an award presentation of the Gold Star Award from New York Giant’s athletes, Victor Cruz and Jason Pierre-Paul, to 10 deserving heroes.
Accelerating Research For Pediatric Brain Tumors
Meet Dr. Mark Souweidane from Weill Cornell Medical Center and listen in as we interview him and two childhood cancer families about his clinical trial that Solving Kids’ Cancer funded for children with brain tumors.
2015: A Year at a Glance for SKC
2015 proved to be a critical year for Solving Kids’ Cancer. Watch as we reflect on all of this year’s accomplishments including the opportunity to ring the closing Nasdaq bell to our exclusive interview with WCBS Radio and Newsweek. Thank you all for a remarkable year!
Understanding the Landscape, Strengthening the Science, Curing and Caring for the Child
Solving Kids’ Cancer’s approach is to understand the research landscape, strengthen the science, cure, and care for the child. The GD2 T Cell Therapy trial at Texas Children’s Hospital is helping children with neuroblastoma like Kyra Kardong – listen to her story.